Skip to content

HEART Camp: Promoting Adherence to Exercise in Patients With Heart Failure

HEART Camp: Promoting Adherence to Exercise in Patients With Heart Failure

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01658670
Acronym
HEART
Enrollment
245
Registered
2012-08-07
Start date
2012-04-01
Completion date
2018-03-01
Last updated
2023-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Keywords

Heart failure, exercise, adherence, quality of life

Brief summary

The purpose of this study is to determine the efficacy of the Heart Failure Exercise and Resistance Training (HEART) Camp behavioral exercise training intervention on long-term adherence to exercise at 18 months in patients with heart failure. The central hypothesis is that the HEART Camp intervention group (HC) will have significantly better adherence to exercise at 18 months.

Detailed description

The objective of this prospective randomized two-group repeated measures experimental design is to determine the efficacy of the HEART (Heart Failure Exercise and Resistance Training) Camp behavioral exercise training intervention on long-term adherence to exercise at 18 months in patients with HF. A sample size of 246 subjects with heart failure will be recruited over a 3 year period. All subjects will receive a cardiopulmonary exercise test and 9 supervised exercise training sessions during a 3 week run-in period prior to randomization. Subjects completing 6 of 9 training sessions will be randomized to the HEART Camp Intervention group (HC) or to an enhanced usual care (EUC) exercise group. The HC intervention group will receive cognitive-behavioral strategies that address the intervention components of knowledge, attitudes, self-efficacy, behavioral self-management skills and social support. The EUC group is provided access to the exercise facility and regular facility staff for the 18 month study period. Our central hypothesis is that the HC group will have significantly better adherence to exercise at 18 months. We will test our hypothesis with the following Specific Aims: Aim 1. To evaluate the effect of HEART Camp on adherence to exercise (measured by self-report and validated by heart rate monitor); Aim 2. To evaluate which components of the HEART Camp intervention mediate the effects of the intervention on adherence; Aim 3. To evaluate the effect of HEART Camp on specific health outcomes; Aim 4. To explore selected demographic variables (age, race, gender, body mass index and left ventricular ejection fraction) as potential moderators of the effect of the HEART Camp intervention on adherence; and Aim 5. To explore the perceptions and experiences that contextualize exercise adherence.

Interventions

The EUC group is provided access to the exercise facility and regular facility staff for the 18 month study period.

BEHAVIORALHEART Camp (HC) Intervention Group

The HC intervention group will be provided access to the exercise facility for the 18 month study period and will also receive the cognitive-behavioral intervention (knowledge, attitudes, self-efficacy, behavioral self-management skills and social support) delivered using both group-based and individual-based strategies.

Sponsors

National Heart, Lung, and Blood Institute (NHLBI)
CollaboratorNIH
Wayne State University
CollaboratorOTHER
Henry Ford Health System
CollaboratorOTHER
University of Nebraska Lincoln
CollaboratorOTHER
University of Nebraska
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosis of heart failure (stage C chronic HF confirmed by echocardiography and clinical evaluation) * 19 years of age or greater * able to speak and read English * telephone access in home * Stable pharmacologic therapy per guidelines for past 30 days

Exclusion criteria

* clinical evidence of decompensated HF * unstable angina pectoris * myocardial infarction, coronary artery bypass surgery, or biventricular pacemaker within the past 6 weeks * orthopedic or neuromuscular disorders preventing participation in aerobic exercise and strength/resistance training * participation in 3 times per week aerobic exercise during the past 8 weeks * cardiopulmonary stress test results that preclude safe exercise training * plans to move more than 50 miles from the exercise site within the next year * peak oxygen uptake (pVO2) in women\>21mL kg min and in men \>24mLkg min * planned or current pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Adherence to exercise.18 monthsAdherence to exercise with 18 months as the primary outcome time point.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 19, 2026